Literature DB >> 8011545

Interleukin 8 in serum in granulocytopenic patients with infections.

A Waage1, D Remick, S Steinshamn, L Deforge, J Lamvik.   

Abstract

Serum levels of interleukin 8 (IL-8) were examined in eight patients with acute myeloid leukaemia during 16 courses of chemotherapy. The patients experienced 14 episodes of fever which occurred in periods with granulocyte counts < 0.5 x 10(9)/l. Febrile episodes were classified as bacteriologically defined infection (n = 6), clinically defined infection (n = 2), and unexplained fever (n = 6). IL-8 was detected in 18/25 (72%), 2/3 (67%) and 3/7 (43%) of the serum samples in the respective groups. In contrast, IL-8 was detected in 22/90 (24%) of the samples taken when no fever was present (P < 0.00003 versus bacteriologically defined infection). The median concentration of IL-8 in samples taken during febrile episodes was 194 ng/ml (range 0-6358 ng/ml) and 0 (range 0-5392 ng/ml) on days without fever (not significant). In three patients with infections caused by, respectively, Streptococcus sanguis, Acinetobacter calcoanitratus and Candida albicans, IL-8 rose to a peak levels and declined during recovery. We conclude that IL-I is released systemically during infections with gram-positive and gram-negative bacteria and Candida albicans in patients with acute myeloid leukaemia and peripheral granulocytopenia due to chemotherapy. However, IL-8 can also be detected when no sign of infection is present.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8011545     DOI: 10.1111/j.1365-2141.1994.tb03249.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

1.  Candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells.

Authors:  S G Filler; A S Pfunder; B J Spellberg; J P Spellberg; J E Edwards
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Endotoxemia in febrile patients with hematological malignancies. Relationship of type of bacteremia, clinical findings and serum cytokine pattern.

Authors:  P Engervall; M Granström; B Andersson; M Kalin; M Björkholm
Journal:  Infection       Date:  1997 Jan-Feb       Impact factor: 3.553

3.  Serum levels of IL-1 beta, sIL-2R, IL-6, IL-8, and TNF-alpha in febrile children with cancer and neutropenia.

Authors:  M Soker; L Colpan; A Ece; C Devecioğlu; K Haspolat
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

4.  Immunomodulatory and protective effects of moxifloxacin against Candida albicans-induced bronchopneumonia in mice injected with cyclophosphamide.

Authors:  Itamar Shalit; Limor Horev-Azaria; Ina Fabian; Hannah Blau; Naam Kariv; Itsak Shechtman; Hannah Alteraz; Yehudith Kletter
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

5.  Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients.

Authors:  Claudi S M Oude Nijhuis; Edo Vellenga; Simon M G J Daenen; Winette T A van der Graaf; Jourik A Gietema; Harry J M Groen; Willem A Kamps; Eveline S J M de Bont
Journal:  Intensive Care Med       Date:  2003-10-16       Impact factor: 17.440

6.  Endothelial cells are main producers of interleukin 8 through Toll-like receptor 2 and 4 signaling during bacterial infection in leukopenic cancer patients.

Authors:  C S M Oude Nijhuis; E Vellenga; S M G J Daenen; W A Kamps; E S J M De Bont
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

7.  Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients.

Authors:  Nuray Buyukberber; Süleyman Buyukberber; Alper Sevinc; Celalettin Camci
Journal:  Med Oncol       Date:  2008-08-07       Impact factor: 3.064

8.  Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.

Authors:  G Fleischhack; D Cipic; J Juettner; C Hasan; U Bode
Journal:  Intensive Care Med       Date:  2000-03       Impact factor: 17.440

9.  Kinetics and correlation with body temperature of circulating interleukin-6, interleukin-8, tumor necrosis factor alpha and interleukin-1 beta in patients with fever and neutropenia.

Authors:  A Engel; W V Kern; G Mürdter; P Kern
Journal:  Infection       Date:  1994 May-Jun       Impact factor: 3.553

10.  Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia.

Authors:  H Schönbohn; M Schuler; K Kolbe; C Peschel; C Huber; W Bemb; W E Aulitzky
Journal:  Ann Hematol       Date:  1995-10       Impact factor: 3.673

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.